Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/04/2007US20070232562 Antiviral nucleosides
10/04/2007US20070232561 Pharmaceutical compositions for promoting wound healing
10/04/2007US20070232560 Treatment of skin with adenosine or adenosine analog
10/04/2007US20070232559 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
10/04/2007US20070232557 Methods and compositions for inhibiting the function of polynucleotide sequences
10/04/2007US20070232556 Methods and compositions for the treatment of neurological diseases and disorders
10/04/2007US20070232555 Suppression of the Hepatocyte growth factor/scatter factor (HGF/SF)-Met signaling pathway by targeting the Met protein tyrosine kinase; treating a c-met tumor or glioblastoma, prostate or gastric cancer
10/04/2007US20070232554 3,6-Bridged 9,12-oxolides
10/04/2007US20070232551 Treatment for Cardiovascular Disease
10/04/2007US20070232549 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/04/2007US20070232538 Uses of polypeptides
10/04/2007US20070232536 Pharmaceutical compositions containing plasma protein
10/04/2007US20070232534 Promote the growth of neurons, which is revealed by the increase in the thickness, length and number of branches in the neurites; stimulating the proliferation of neuron stem cells using propolin
10/04/2007US20070232533 Use of Vinca Alkaloids and Salts Thereof
10/04/2007US20070232529 Active agent delivery systems and methods for protecting and administering active agents
10/04/2007US20070232528 Formulation comprising histone deacetylase inhibitors
10/04/2007US20070232521 that can trap isotopic fluorine so that when the biological molecule accumulates in the desired type of cell, the isotopic fluorine is imaged by PET scan
10/04/2007US20070231861 Production of Isoprenoids
10/04/2007US20070231848 Abeta-heme peroxidase
10/04/2007US20070231418 Emulsion containing a plant extract, method for producing said emulsion and for obtaining said plant extract
10/04/2007US20070231411 Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
10/04/2007US20070231410 Disease modifying anti-arthritic activity of 2-Methoxyestradiol
10/04/2007US20070231407 Method of treating gallium-nitrate resistant tumors using gallium-containing compounds
10/04/2007US20070231405 Compositions and Methods Using Same for Treating Neurodegenerative Disorders
10/04/2007US20070231404 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
10/04/2007US20070231396 Medication spray formulation
10/04/2007US20070231395 Solid Pharmaceutical Preparation for Dialysis
10/04/2007US20070231393 System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
10/04/2007US20070231386 Novel Pharmaceutical Formulation Containing a Biguanide and an Agiotension Antagonist
10/04/2007US20070231385 Controlled Release Pharmaceutical Composition and a Process for Preparing the Same
10/04/2007US20070231383 Cr3O(carboxylate)6(ligand)3]+ (3)wherein carboxylate is a C2-C5 alkyl carboxylate and wherein the ligand is a ligand that (i) renders the chromium complex insoluble or only slightly soluble in water and (ii) is acid labile; diabetes
10/04/2007US20070231382 Pharmaceutical composition
10/04/2007US20070231381 Controlled-release dosage forms comprising zolpidem or a salt thereof
10/04/2007US20070231379 Liposome-entrapped topoisomerase inhibitors
10/04/2007US20070231377 Compositions for promoting hair growth
10/04/2007US20070231376 Methods and compositions for modulating axonal outgrowth of central nervous system neurons
10/04/2007US20070231375 Liposome combination and the use thereof
10/04/2007US20070231373 Transdermal Steriod for Formulation
10/04/2007US20070231371 Nutritional system and methods for increasing longevity
10/04/2007US20070231367 Bitterness-masking particulate jelly beverage
10/04/2007US20070231363 Coatings formed from stimulus-sensitive material
10/04/2007US20070231361 Use of Fatty Acids to Inhibit the Growth of Aneurysms
10/04/2007US20070231360 Neural conduit agent dissemination
10/04/2007US20070231359 Methods and compositions for piercing studs with bioactive polymer coating
10/04/2007US20070231353 Compositons and methods for maintaining eyelid hygiene
10/04/2007US20070231352 Mucoadhesive thermoresponsive medicament-carrier composition
10/04/2007US20070231345 Medicament containing natural leucotriene inhibitors singly or in combination with bioavailable organic selenium supplement for hyperproliferative dermatological conditions and therapeutic methods thereof
10/04/2007US20070231338 Production and Use of the Methotrexate-Albumin Conjugate as an Immunosuppressive Agent in Gvhd
10/04/2007US20070231335 Compositions and methods for treating Gram positive bacterial infection in a mammalian subject
10/04/2007US20070231334 Combination therapy for anthrax using antibiotics and protease inhibitors
10/04/2007US20070231332 Inhibition of Cancer Metastasis
10/04/2007US20070231330 Method for the improvement of neuronal regeneration
10/04/2007US20070231326 Immunological Methods of Treating Cancer
10/04/2007US20070231323 Compositions and methods for the diagnosis and treatment of tumors of glial origin
10/04/2007US20070231321 Heavy and light chain variable domains; fv fragments; vectors, host cells; for oral diseases such as periodontitis and dental caries prevented effectively by passive immunization
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007US20070231317 S100 Protein Inhibitors for Treating Leukemia
10/04/2007US20070231314 Polypeptides and compositions derived from the horny layer of the epidermis and its use
10/04/2007US20070231313 Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
10/04/2007US20070231312 Nutritional supplement for pregnant females
10/04/2007US20070231307 Energy assisted stem cell extract
10/04/2007US20070231304 Prognostic factors for anti-hyperproliferative disease gene therapy
10/04/2007US20070231298 Cytokine-expressing cancer immunotherapy combinations
10/04/2007US20070231295 Antimicrobial Silicon Oxide Flakes
10/04/2007US20070231294 Ophthalmic Compositions Containing A Synergistic Combination Of Three Polymers
10/04/2007US20070231293 Methods and systems for releasing silicone hydrogel ophthalmic lenses using surfactants
10/04/2007US20070231292 Methods and systems for leaching silicone hydrogel ophthalmic lenses
10/04/2007US20070231291 Polymeric anti-microbial agents
10/04/2007US20070231288 Cosmetic use of d-ribose and method thereof
10/04/2007US20070231285 Method for regulating the appearance of skin containing combination of skin care actives
10/04/2007US20070231284 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb
10/04/2007US20070231274 Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
10/04/2007US20070231273 Method for Decreasing Blood Glucose Levels
10/04/2007US20070231272 Process for Preparing Inhalable Powders
10/04/2007US20070231271 Topical composition of biocellulose as gel, spray-aerosol, cream and/or aqueous for the treatment of epithelial lesions
10/04/2007US20070231269 Analgesics
10/04/2007US20070231268 Methods and compositions for deterring abuse of orally administered pharmaceutical products
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007US20070231265 Cell growth factor of hair stem cell factor induces migration of melanocyte stem cells and keratinocyte stem cells to increase in hair follicles, amino acids and vitamins, and minoxidil; animal models
10/04/2007US20070231264 Mammalian cytokine; related reagents
10/04/2007US20070231263 Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders
10/04/2007US20070231261 Aberrantly over-expressed in at least some cancers, such as prostate and bladder cancers
10/04/2007US20070231255 Method for the Treatment of Mammalian Skin Tissues Via Pulse Irradiation in the Presence of a Photoactive Compound
10/04/2007US20070229732 Chiral compounds
10/04/2007DE202007007542U1 Aminosäure-Mineral-Peptid-Komplex, insbesondere quantenmechanisch modifiziert, als Arzneimittel zur Behandlung von Demenzerkrankungen Amino acid-mineral-peptide complex, in particular quantum mechanically modified as drugs for the treatment of dementia
10/04/2007DE10262176B4 Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung Process for the preparation of antibiotically coated porous bodies as well as use of
10/04/2007DE10227935B4 Verfahren zur Herstellung einer antibiotische Beschichtung von porösen Körpern sowie Verwendung A process for preparing a antibiotic coating of porous bodies, and using
10/04/2007DE102006016285A1 Medicament used to reduce risk of e.g. heart disease and urinary tract disease, comprises 5-methyl-(6S)-tetrahydrofolate, estrogen and/or gestagene, vitamin B6 and/or vitamin B2 and auxiliary or carrier materials
10/04/2007DE102006015544A1 Topisch zu applizierende Zusammensetzung Topical application composition
10/04/2007DE102006014688A1 Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen Azolopyridin-3-one derivatives as inhibitors of lipases, and phospholipases
10/04/2007DE102006014685A1 Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen Imidazo-pyridin-2-one derivatives as inhibitors of lipases, and Phospholiphasen
10/04/2007DE102006014390A1 Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung Associates of xanthates with cyclodextrins and their use
10/04/2007DE102006013957A1 Substituierte N-Benzyl-N-phenylbenzolsulfonamide Substituted N-benzyl-N-phenylbenzolsulfonamide
10/04/2007DE102006013307B3 Tergurid/Protergurid zur Behandlung von chronischen Schmerzen Terguride / proterguride for the treatment of chronic pain
10/04/2007DE102006012874A1 Mittel zur effektiven Senkung der Konzentrationen des C-reaktiven Proteins (CRP) Means for effectively reducing the concentrations of C-reactive protein (CRP)
10/04/2007DE102005044813A1 Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln Substituted spiro-compounds and their use for preparing medicaments
10/04/2007DE10129119B4 Kristalline Salze von Benzoylbenzofuran-Derivaten, insbesondere Crystalline salts of benzoylbenzofuran-derivatives, in particular von[2-(4-{1-[2-((S)-sec.-Butoxycarbonylmethyl)-benzofuran-3-carbonyl]-methanoyl}-2,6-diiod-phenoxy)-ethyl]-diethylamino und [2-(4-{1-[(3-Methyl-2-(S)-Butoxycarbonylmethyl)-benzofuran-3-carbonyl]- methanoyl}-2,6-diiodphenoxy)-ethyl]-diethylamino, deren Verwendung und Herstellung sowie diese Salze enthaltende Arzneimittel and [2- (4- {1 - [(3-methyl-2- (S) -Butoxycarbonylmethyl) benzofuran-3-carbonyl] - methanoyl} -2,6-diiodphenoxy) -ethyl] -diethylamino, their use and preparation and pharmaceutical compositions containing these salts
10/04/2007CA2681668A1 Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat
10/04/2007CA2681639A1 Compounds and methods for treatment of disorders associated with er stress
10/04/2007CA2680789A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
1 ... 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575 3576 3577 3578 ... 7860